Skip to content
10-Q

Quarterly Report

Cell Source, Inc. CLCS

0001493152-23-033011

← back to feed
Filed
Sep 19, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Sep 15, 2023 38.2M sh
Cash And Equivalents Q2 2023 · Jun 30, 2023 $21.99K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $222.67K
Total Liabilities Q2 2023 · Jun 30, 2023 $15.31M
Total Liabilities Q2 2023 · Dec 31, 2022 $13.04M
Total Assets Q2 2023 · Jun 30, 2023 $362.33K
Total Assets Q2 2023 · Dec 31, 2022 $409.85K
Shares Diluted Q2 2023 · Jun 30, 2022 34.44M sh
Shares Diluted Q2 2023 · Jun 30, 2022 34.42M sh
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$1.33M
Stockholders Equity Q2 2023 · Jun 30, 2022 −$10.77M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$10M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$9.83M
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.04
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.09
Eps Basic Q2 2023 · Jun 30, 2022 −$0.04
Eps Basic Q2 2023 · Jun 30, 2022 −$0.09
Net Income Q2 2023 · Jun 30, 2022 −$1.29M
Net Income Q2 2023 · Jun 30, 2022 −$2.58M
Net Income Q2 2023 · Mar 31, 2022 −$1.29M
Operating Income Q2 2023 · Jun 30, 2022 −$1.03M
Operating Income Q2 2023 · Jun 30, 2022 −$2.09M